By expenditures
| Name | Title | Type |
|---|---|---|
| Helene Kafka | Vice President Of Finance | Auditee |
| Martha Parker | Partner | Auditee |
| Paco Velez | EXECUTIVE DIRECTOR | Auditee |
| Martha Parker, CPA | PARTNER | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 373471 | 2024 | 2025-12-08 | CITRIN COOPERMAN & COMPANY | $20.92M |
| 301959 | 2023 | 2024-04-01 | Keefe McCullough | $4.20M |
| 45461 | 2022 | 2023-03-30 | Keefe McCullough | $16.89M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 373471 | 2024 | 2025-12-08 | 1163629 | 2024-002 | Material Weakness | Yes | AB |
| 45461 | 2022 | 2023-03-30 | 619426 | 2022-002 | Significant Deficiency | Yes | E |
| 45461 | 2022 | 2023-03-30 | 619425 | 2022-001 | Significant Deficiency | Yes | AB |
| 45461 | 2022 | 2023-03-30 | 619424 | 2022-002 | Significant Deficiency | Yes | E |
| 45461 | 2022 | 2023-03-30 | 619423 | 2022-001 | Significant Deficiency | Yes | AB |
| 45461 | 2022 | 2023-03-30 | 619422 | 2022-002 | Significant Deficiency | Yes | E |
| 45461 | 2022 | 2023-03-30 | 619421 | 2022-001 | Significant Deficiency | Yes | AB |
| 45461 | 2022 | 2023-03-30 | 619420 | 2022-002 | Significant Deficiency | Yes | E |
| 45461 | 2022 | 2023-03-30 | 619419 | 2022-001 | Significant Deficiency | Yes | AB |
| 45461 | 2022 | 2023-03-30 | 619418 | 2022-002 | Significant Deficiency | Yes | E |
| 45461 | 2022 | 2023-03-30 | 619417 | 2022-001 | Significant Deficiency | Yes | AB |
| 45461 | 2022 | 2023-03-30 | 619416 | 2022-002 | Significant Deficiency | Yes | E |
| 45461 | 2022 | 2023-03-30 | 619415 | 2022-001 | Significant Deficiency | Yes | AB |
| 45461 | 2022 | 2023-03-30 | 619414 | 2022-002 | Significant Deficiency | Yes | E |
| 45461 | 2022 | 2023-03-30 | 619413 | 2022-001 | Significant Deficiency | Yes | AB |
| 45461 | 2022 | 2023-03-30 | 619412 | 2022-002 | Significant Deficiency | Yes | E |
| 45461 | 2022 | 2023-03-30 | 619411 | 2022-001 | Significant Deficiency | Yes | AB |
| 45461 | 2022 | 2023-03-30 | 42984 | 2022-002 | Significant Deficiency | Yes | E |
| 45461 | 2022 | 2023-03-30 | 42983 | 2022-001 | Significant Deficiency | Yes | AB |
| 45461 | 2022 | 2023-03-30 | 42982 | 2022-002 | Significant Deficiency | Yes | E |
| 45461 | 2022 | 2023-03-30 | 42981 | 2022-001 | Significant Deficiency | Yes | AB |
| 45461 | 2022 | 2023-03-30 | 42980 | 2022-002 | Significant Deficiency | Yes | E |
| 45461 | 2022 | 2023-03-30 | 42979 | 2022-001 | Significant Deficiency | Yes | AB |
| 45461 | 2022 | 2023-03-30 | 42978 | 2022-002 | Significant Deficiency | Yes | E |
| 45461 | 2022 | 2023-03-30 | 42977 | 2022-001 | Significant Deficiency | Yes | AB |
| 45461 | 2022 | 2023-03-30 | 42976 | 2022-002 | Significant Deficiency | Yes | E |
| 45461 | 2022 | 2023-03-30 | 42975 | 2022-001 | Significant Deficiency | Yes | AB |
| 45461 | 2022 | 2023-03-30 | 42974 | 2022-002 | Significant Deficiency | Yes | E |
| 45461 | 2022 | 2023-03-30 | 42973 | 2022-001 | Significant Deficiency | Yes | AB |
| 45461 | 2022 | 2023-03-30 | 42972 | 2022-002 | Significant Deficiency | Yes | E |
| 45461 | 2022 | 2023-03-30 | 42971 | 2022-001 | Significant Deficiency | Yes | AB |
| 45461 | 2022 | 2023-03-30 | 42970 | 2022-002 | Significant Deficiency | Yes | E |
| 45461 | 2022 | 2023-03-30 | 42969 | 2022-001 | Significant Deficiency | Yes | AB |